Christopher John Kenney Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Christopher John Kenney is Chief Medical Officer of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of XENE, which is worth approximately $0. The most recent transaction as insider was on Mar 24, 2023, when has been sold 700 shares (Common Shares) at a price of $35.01 per share, resulting in proceeds of $24,507. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

CHRISTOPHER JOHN KENNEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2023
SELL
Open market or private sale
$24,507 $35.01 p/Share
700 Reduced 100.0%
0 Common Shares
Jan 21 2022
BUY
Open market or private purchase
$20,167 $28.81 p/Share
700 Added 50.0%
700 Common Shares
CJK

Christopher John Kenney

Chief Medical Officer
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE